About
Technology
Issues
FAQ
Links
Official Page
192TiP: NEPTUNE: A global, phase 3 study of durvalumab (MEDI4736) plus tremelimumab combination therapy versus standard of care (SoC) platinum-based chemotherapy in the first-line treatment of patients (pts) with advanced or metastatic NSCLC
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.